Predictive factors for omitting lymphadenectomy in patients with node-positive breast cancer treated with neo-adjuvant systemic therapy. 2020

Sergi Fernandez-Gonzalez, and Catalina Falo, and Maria J Pla, and Paula Verdaguer, and Diana Nuñez, and Anna Guma, and Teresa Soler, and Andrea Vethencourt, and Silvia Vázquez, and Maria Eulalia Fernandez-Montoli, and Miriam Campos, and Sonia Pernas, and Miguel Gil, and Jordi Ponce, and Amparo Garcia-Tejedor
Multidisciplinary Breast Cancer Unit, Department of Gynecology, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain.

A pathologic complete response (pCR) in the axilla occurs in 30%-40% of patients with initially node-positive breast cancer after neo-adjuvant chemotherapy (NACT). Debate persists about whether to perform systematic axillary lymphadenectomy (ALND) in patients with initial node-positive disease and clinical complete response after NACT. We aimed to identify predictive factors of axillary pCR (ypN0) after NACT. This retrospective study analyzed data for all patients with initial biopsy-proven node-positive disease who underwent ALND after NACT between June 2008 and December 2016 at our institution. Clinical and pathologic features, recurrence and specific mortality rates were compared between patients who achieved an axillary pCR and those who did not (ypN0 vs ypN+, respectively). A total of 331 patients were included, of whom 128 (38.7%) became ypN0 after NACT. Among patients with >2 suspicious axillary lymph nodes before treatment, 54 (38%) achieved ypN0 status. The independent predictors of ypN0 were Ki-67 > 30 (OR 1.98; 95% CI, 1.146-3.381), HER2 positivity (OR 2.6; 95% CI, 1.354-5.108), nonluminal molecular-like subtype (OR 4.15; 95% CI, 2.068-5.108), and clinical complete response, defined as negative clinical and ultrasonographic findings (OR 2.8; 95% CI, 1.110-7.081). After a mean follow-up of 61 months, distant disease-free and overall survival rates were higher in patients with ypN0 disease (HR 4.14; 95% CI, 2.03-8.43) than ypN+ patients. Complete clinical response and the presence of nonluminal molecular-like subtypes independently predicted ypN0. Patients meeting these criteria might be suitable form omitting ALND and just performing targeted axillary procedures to patients meeting these criteria.

UI MeSH Term Description Entries
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001365 Axilla Area of the human body underneath the SHOULDER JOINT, also known as the armpit or underarm. Armpit,Underarm
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D020360 Neoadjuvant Therapy Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, IMMUNOTHERAPY, HYPERTHERMIA, INDUCED etc.) that is given before the main therapy. Neoadjuvant Chemoradiation,Neoadjuvant Chemoradiation Therapy,Neoadjuvant Chemoradiation Treatment,Neoadjuvant Chemoradiotherapy,Neoadjuvant Chemotherapy,Neoadjuvant Chemotherapy Treatment,Neoadjuvant Radiation,Neoadjuvant Radiation Therapy,Neoadjuvant Radiation Treatment,Neoadjuvant Radiotherapy,Neoadjuvant Systemic Therapy,Neoadjuvant Systemic Treatment,Neoadjuvant Treatment,Chemoradiation Therapy, Neoadjuvant,Chemoradiation Treatment, Neoadjuvant,Chemoradiation, Neoadjuvant,Chemoradiotherapy, Neoadjuvant,Chemotherapy Treatment, Neoadjuvant,Chemotherapy, Neoadjuvant,Neoadjuvant Chemoradiation Therapies,Neoadjuvant Chemoradiation Treatments,Neoadjuvant Chemoradiations,Neoadjuvant Chemoradiotherapies,Neoadjuvant Chemotherapies,Neoadjuvant Chemotherapy Treatments,Neoadjuvant Radiation Therapies,Neoadjuvant Radiation Treatments,Neoadjuvant Radiations,Neoadjuvant Radiotherapies,Neoadjuvant Systemic Therapies,Neoadjuvant Systemic Treatments,Neoadjuvant Therapies,Neoadjuvant Treatments,Radiation Therapy, Neoadjuvant,Radiation Treatment, Neoadjuvant,Radiation, Neoadjuvant,Radiotherapy, Neoadjuvant,Systemic Therapy, Neoadjuvant,Systemic Treatment, Neoadjuvant,Therapy, Neoadjuvant,Therapy, Neoadjuvant Chemoradiation,Therapy, Neoadjuvant Radiation,Therapy, Neoadjuvant Systemic,Treatment, Neoadjuvant,Treatment, Neoadjuvant Chemoradiation,Treatment, Neoadjuvant Chemotherapy,Treatment, Neoadjuvant Radiation,Treatment, Neoadjuvant Systemic
D021701 Sentinel Lymph Node Biopsy A diagnostic procedure used to determine whether LYMPHATIC METASTASIS has occurred. The SENTINEL LYMPH NODE is the first lymph node to receive drainage from a neoplasm. Biopsy, Sentinel Lymph Node,Lymph Node Biopsy, Sentinel

Related Publications

Sergi Fernandez-Gonzalez, and Catalina Falo, and Maria J Pla, and Paula Verdaguer, and Diana Nuñez, and Anna Guma, and Teresa Soler, and Andrea Vethencourt, and Silvia Vázquez, and Maria Eulalia Fernandez-Montoli, and Miriam Campos, and Sonia Pernas, and Miguel Gil, and Jordi Ponce, and Amparo Garcia-Tejedor
January 1992, Anticancer research,
Sergi Fernandez-Gonzalez, and Catalina Falo, and Maria J Pla, and Paula Verdaguer, and Diana Nuñez, and Anna Guma, and Teresa Soler, and Andrea Vethencourt, and Silvia Vázquez, and Maria Eulalia Fernandez-Montoli, and Miriam Campos, and Sonia Pernas, and Miguel Gil, and Jordi Ponce, and Amparo Garcia-Tejedor
June 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Sergi Fernandez-Gonzalez, and Catalina Falo, and Maria J Pla, and Paula Verdaguer, and Diana Nuñez, and Anna Guma, and Teresa Soler, and Andrea Vethencourt, and Silvia Vázquez, and Maria Eulalia Fernandez-Montoli, and Miriam Campos, and Sonia Pernas, and Miguel Gil, and Jordi Ponce, and Amparo Garcia-Tejedor
March 2023, Cancers,
Sergi Fernandez-Gonzalez, and Catalina Falo, and Maria J Pla, and Paula Verdaguer, and Diana Nuñez, and Anna Guma, and Teresa Soler, and Andrea Vethencourt, and Silvia Vázquez, and Maria Eulalia Fernandez-Montoli, and Miriam Campos, and Sonia Pernas, and Miguel Gil, and Jordi Ponce, and Amparo Garcia-Tejedor
January 2009, The breast journal,
Sergi Fernandez-Gonzalez, and Catalina Falo, and Maria J Pla, and Paula Verdaguer, and Diana Nuñez, and Anna Guma, and Teresa Soler, and Andrea Vethencourt, and Silvia Vázquez, and Maria Eulalia Fernandez-Montoli, and Miriam Campos, and Sonia Pernas, and Miguel Gil, and Jordi Ponce, and Amparo Garcia-Tejedor
January 2006, Advances in surgery,
Sergi Fernandez-Gonzalez, and Catalina Falo, and Maria J Pla, and Paula Verdaguer, and Diana Nuñez, and Anna Guma, and Teresa Soler, and Andrea Vethencourt, and Silvia Vázquez, and Maria Eulalia Fernandez-Montoli, and Miriam Campos, and Sonia Pernas, and Miguel Gil, and Jordi Ponce, and Amparo Garcia-Tejedor
November 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
Sergi Fernandez-Gonzalez, and Catalina Falo, and Maria J Pla, and Paula Verdaguer, and Diana Nuñez, and Anna Guma, and Teresa Soler, and Andrea Vethencourt, and Silvia Vázquez, and Maria Eulalia Fernandez-Montoli, and Miriam Campos, and Sonia Pernas, and Miguel Gil, and Jordi Ponce, and Amparo Garcia-Tejedor
September 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
Sergi Fernandez-Gonzalez, and Catalina Falo, and Maria J Pla, and Paula Verdaguer, and Diana Nuñez, and Anna Guma, and Teresa Soler, and Andrea Vethencourt, and Silvia Vázquez, and Maria Eulalia Fernandez-Montoli, and Miriam Campos, and Sonia Pernas, and Miguel Gil, and Jordi Ponce, and Amparo Garcia-Tejedor
January 1999, Swiss surgery = Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera,
Sergi Fernandez-Gonzalez, and Catalina Falo, and Maria J Pla, and Paula Verdaguer, and Diana Nuñez, and Anna Guma, and Teresa Soler, and Andrea Vethencourt, and Silvia Vázquez, and Maria Eulalia Fernandez-Montoli, and Miriam Campos, and Sonia Pernas, and Miguel Gil, and Jordi Ponce, and Amparo Garcia-Tejedor
February 2000, The Medical letter on drugs and therapeutics,
Sergi Fernandez-Gonzalez, and Catalina Falo, and Maria J Pla, and Paula Verdaguer, and Diana Nuñez, and Anna Guma, and Teresa Soler, and Andrea Vethencourt, and Silvia Vázquez, and Maria Eulalia Fernandez-Montoli, and Miriam Campos, and Sonia Pernas, and Miguel Gil, and Jordi Ponce, and Amparo Garcia-Tejedor
February 2002, Journal of gastroenterology and hepatology,
Copied contents to your clipboard!